A database of FDA approved therapeutic peptides and proteins
ID1454 | ThPPIDTh1084 | NameBecaplermin | Peptide SequenceSLGSLTIAEPAMIAECKTRT Full view | Length109 | Functional ClassificationIb | DiseaseCardiac | BrandREGRANEX | CompanyOMJ Pharmaceuticals, Inc. San German, Puerto Rico | Physical AppearanceGel: 0.01 %; clear, colorless to straw-colored gel | Route of AdministartionExternal use only | CategoryAngiogenesis Inducing Agents | TargetT-cell surface glycoprotein CD1a,Major histocompatibility complex class I-related gene protein,Integrin alpha-L,T-lymphocyte activation antigen CD86,Low affinity immunoglobulin gamma Fc region receptor II-b,T-cell surface glycoprotein CD4,Integrin beta-1,Integrin alpha-V,Integrin beta-3 |